Interview with: Bruce L. Hollander, Chairman, President and CEO - featuring: their products for the dental implant and tissue regeneration markets.

CURRENT ISSUE |  COVER ARCHIVES  |  INDEX  |  CONTACT  |  FINANCIALS |  MARKETING SERVICES | HOME PAGE

CEOCFO-Members Login
Become A Member!

This is a printer friendly page!

BoneGen-TR bone augmentation material along with patented Laser-LokŪ dental implants position BioLok International for significant growth and continued market share gains



Healthcare
Dental Products and Materials
(BLLI-OTC: BB)

BioLok International Inc.




Bruce L. Hollander
Chairman, President and CEO

Interview conducted by:
Lynn Fosse, Senior Editor
CEOCFOinterviews.com
April 26, 2006

disclaimers

Any reproduction or further distribution of this article without the express written consent of CEOCFOinterviews.com is prohibited.

“Today, aesthetics and demographic trends are driving significant demand for dental implants. Aesthetic dentistry as well as an expanding population that is living longer requires implants that last a lifetime and have other important qualities. The first quality is initial stability, the second is long-term stability of the dental implant, and then you have to have the ability to stop epithelial down growth so that infection doesn’t set in. You also would need to give soft tissue time to attach to the implant, and, lastly, you have to maintain bone attachment to the implant. We are the only surface in the world that has FDA approval to say that we can do these things. Therefore, BioLok’s Laser-Lok implant is an increasingly sought after product with a superior surface.” - Bruce L. Hollander